147 related articles for article (PubMed ID: 37694309)
21. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
22. Being limited by Parkinson's disease and struggling to keep up exercising; is the group the glue?
Claesson IM; Ståhle A; Johansson S
Disabil Rehabil; 2020 May; 42(9):1270-1274. PubMed ID: 30621467
[No Abstract] [Full Text] [Related]
23. Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson's disease.
Sebring K; Shattuck J; Berk J; Boersma I; Sillau S; Kluger BM
Palliat Med; 2018 Oct; 32(9):1522-1528. PubMed ID: 30015552
[TBL] [Abstract][Full Text] [Related]
24. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.
Ghosh B; Mishra A; Sengupta P
J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291
[TBL] [Abstract][Full Text] [Related]
25. Respiratory crisis in Parkinson's disease.
Kundu BC
Br Med J; 1978 Feb; 1(6109):366-7. PubMed ID: 624003
[No Abstract] [Full Text] [Related]
26. Psychiatric commentary addressing the article titled "Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus".
Citrome L
CNS Spectr; 2018 Dec; 23(6):355-357. PubMed ID: 30588903
[TBL] [Abstract][Full Text] [Related]
27. Non-motor symptoms of Parkinson's disease.
Carroll V; Rossiter R; Blanchard D
Aust J Gen Pract; 2021 Nov; 50(11):812-817. PubMed ID: 34713279
[TBL] [Abstract][Full Text] [Related]
28. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
; Nalls MA; Plagnol V; Hernandez DG; Sharma M; Sheerin UM; Saad M; Simón-Sánchez J; Schulte C; Lesage S; Sveinbjörnsdóttir S; Stefánsson K; Martinez M; Hardy J; Heutink P; Brice A; Gasser T; Singleton AB; Wood NW
Lancet; 2011 Feb; 377(9766):641-9. PubMed ID: 21292315
[TBL] [Abstract][Full Text] [Related]
29. Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".
Mestre TA; Eberly S; Tanner C; Grimes D; Lang AE; Oakes D; Marras C
Parkinsonism Relat Disord; 2019 Sep; 66():245-246. PubMed ID: 30655161
[No Abstract] [Full Text] [Related]
30. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
31. Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease.
Jain S; Siegle GJ; Gu C; Moore CG; Ivanco LS; Studenski S; Greenamyre JT; Steinhauer SR
Mov Disord; 2011 Jun; 26(7):1344-7. PubMed ID: 21506163
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
Oertel WH
Arzneimittelforschung; 1995 Mar; 45(3A):386-9. PubMed ID: 7763330
[TBL] [Abstract][Full Text] [Related]
33. Addressing sexuality and intimacy in people living with Parkinson's during palliative care and at the end of life.
Wright J
Br J Nurs; 2019 Jun; 28(12):772-779. PubMed ID: 31242112
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group.
The F
J Neurol Neurosurg Psychiatry; 1997 Sep; 63(3):394-5. PubMed ID: 9328263
[TBL] [Abstract][Full Text] [Related]
35. Active assistive forced exercise provides long-term improvement to gait velocity and stride length in patients bilaterally affected by Parkinson's disease.
Stuckenschneider T; Helmich I; Raabe-Oetker A; Froböse I; Feodoroff B
Gait Posture; 2015 Oct; 42(4):485-90. PubMed ID: 26319218
[TBL] [Abstract][Full Text] [Related]
36. Commentary on "The Neuropsychiatry of Parkinson's Disease: A Perfect Storm".
Friedman JH
Am J Geriatr Psychiatry; 2019 Sep; 27(9):1019-1021. PubMed ID: 30987802
[No Abstract] [Full Text] [Related]
37. Grammatical abilities in Parkinson's disease: evidence from written sentences.
Small JA; Lyons K; Kemper S
Neuropsychologia; 1997 Dec; 35(12):1571-6. PubMed ID: 9460727
[TBL] [Abstract][Full Text] [Related]
38. Mood Disorders and Anxiety in Parkinson's Disease: Current Concepts.
Lintel H; Corpuz T; Paracha SU; Grossberg GT
J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):280-288. PubMed ID: 34219518
[TBL] [Abstract][Full Text] [Related]
39. Parkinson's disease and essential tremor in families of patients with early-onset Parkinson's disease.
Marttila RJ; Rinne UK
J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):429-31. PubMed ID: 3361336
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors of Parkinson's disease in The Netherlands.
Hofman A; Collette HJ; Bartelds AI
Neuroepidemiology; 1989; 8(6):296-9. PubMed ID: 2586699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
